GSK
NYSE
$50.05
GSK Plc (GSK)
GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related consumer products in the UK, US and internationally. The company is headquartered in Brentford, the United Kingdom.
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Hold
Target: $58.08 (+16.06%)
Market Cap
$105B
PEG Ratio
0.10
Profit Margin
22.8%
P/E Ratio
12.10
Price Chart
Valuation
Market Cap$105B
P/E12.10
Forward P/E21.69
PEG0.10
P/S3.22
P/B4.37
Profitability
Total Revenue (TTM)$43B
Gross Profit (TTM)$32B
EBITDA$15B
Profit Margin22.8%
Operating Margin30.1%
EPS$4.25
Financial Health
Debt-to-Equity106.7%
Free Cash Flow Yield8.03%
Dividend Yield3.47%
Growth & Risk
EPS 5Y CAGR+4.65%
Revenue 5Y CAGR+0.63%
FCF 5Y CAGR-0.36%
Dividends 5Y CAGR+1.34%
Beta (5Y)0.23
Sharpe Ratio1.30